Custom service
Protein Extraction Services
Native protein from the source material, in the fraction you need.
Extraction is the step that determines whether the rest of the project works. A protease that was never inhibited, a buffer that oxidised the target, a homogenisation that emulsified a membrane fraction into the cytosolic one — each of these destroys the protein before purification begins, and none of it is visible until the assay fails. Extraction is designed around the target's chemistry: where it lives, what destroys it, and what fraction the downstream assay actually needs.
The workflow is fraction-aware. Cytosolic extraction with protease and phosphatase inhibitors; membrane fractions with mild detergent; nuclear extraction with sequential salt steps; secreted proteins collected from conditioned medium with concentration. Subcellular fractionation is verified by marker proteins, so the claim that a fraction is enriched is supported by measurement rather than by protocol adherence.
Source material adds its own variables. Plant tissue brings phenolics and pigments that bind proteins; plasma brings albumin at fifty-fold excess; egg white brings proteases and high salt; milk brings casein micelles. Each source has a known counter-strategy, applied at extraction, and the extraction report documents what was used and what the recovery was.
Extraction services are used when the source material is difficult, when the fraction matters — membrane or nuclear targets — and when a laboratory lacks the capacity to process kilograms of tissue.
It is not needed when the protein can simply be recombinantly expressed, which is cheaper and cleaner than extracting a natural source for most research targets.
Each extraction is delivered with total protein, target presence and recovery per step, fractionation verification by marker proteins, and the full buffer and process documentation. Storage conditions and hold times are recorded for every aliquot.
Service Highlights
- Fraction-aware design. Cytosolic, membrane, nuclear and secreted fractions extracted with buffers matched to each, verified by marker proteins.
- Protease and PTM protection. Inhibitor cocktails matched to the target class — phosphatase inhibitors for phosphoproteins, metal chelators where relevant.
- Difficult sources handled. Plant phenolics, plasma albumin, milk casein and egg proteases countered with documented strategies.
- Native conditions preserved. Extraction buffers matched to the target's pH, salt and redox requirements.
- Recovery reported. Yield per gram of starting material, with the losses at each step visible in the report.
- Scale matched to need. Milligram-scale analytical extractions through kilogram tissue processing.
How the work runs
Target and source review
Localisation, stability, degradation risks and downstream assay reviewed; extraction strategy designed.
Buffer design
Extraction buffer composed for the target — inhibitors, detergent, redox, pH — and validated on a small sample.
Extraction
Homogenisation and extraction at the required scale, temperature-controlled throughout.
Fractionation
Subcellular or soluble/insoluble separation, with enrichment verified by marker proteins.
Clarification and QC
Centrifugation and filtration; total protein, target presence and recovery measured.
Delivery
Extract supplied clarified and stored as required, with the extraction report.
Specifications & timeline
- Sources
- Animal tissue, cell culture, plant tissue, plasma, milk, egg, microbial biomass
- Fractions
- Cytosolic, membrane, nuclear, mitochondrial, secreted
- Scale
- 1 g tissue to 10 kg biomass per campaign
- Verification
- Marker proteins for fractionation, target assay where available
- Timeline
- 1–3 weeks per extraction
Related Products
- Recombinant ProteinsGrowth factors, cytokines and antigens produced across E. coli, yeast, insect and mammalian hosts — over 10,000 items on the shelf and ready to move.
- Native ProteinsIsolated directly from natural sources, preserving native post-translational modifications and conformational epitopes that recombinant systems can miss.
- Monoclonal AntibodiesRecombinant and hybridoma clones characterised for Western blot, IHC, immunofluorescence, ELISA and flow cytometry — application data included.
Next step
Tell us the target, we will tell you what is feasible
Send the sequence, assay format and sensitivity you need. You will get a technical assessment — recommended platform, timeline and the risks worth knowing before you commit budget.